Amit K. Verma, M.B.B.S is a Professor in the Department of Oncology (Medical Oncology), Department of Medicine (Oncology & Hematology) and Department of Developmental & Molecular Biology, Director of Division of Hemato-Oncology Montefiore Department of Oncology and Associate Director of Translational Science Montefiore Einstein Comprehensive Cancer Center at Albert Einstein College of Medicine.
Amit’s research focusses on molecular pathogenesis of Myelodysplastic syndrome (MDS) to identify targetable pathways for treatment of this disease. His professional interests include targeting signal transduction in hematologic malignancies, targeting aberrant stem and progenitor cells in myelodysplastic neoplasms, Epigenomic analysis of tumors, and clinical studies in myelodysplastic syndromes. Amit’s work has led to clinical trials with Luspatercept, Galunisertib, emavusertib (CA-4948), ARRY-614 and various other promising agents in MDS. Amit has also worked with 9/11 first responders and has shown that 10% of the 9/11 firefighters have clonal hematopoiesis – an incidence more than two to three times greater than in non-WTC firefighters. His team continues to investigate the association between environmental exposures and cancer in in vulnerable populations. He is also involved in early stage clinical trials with novel agents in MDS.